Literature DB >> 2536522

Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).

R Andreesen1, W Brugger, G W Löhr, K J Bross.   

Abstract

The normal precursor of the neoplastic cell in Hodgkin's lymphoma is still unknown. Previous reports on the expression of the Hodgkin's cell-associated antigen Ki-1, CD30, on normal cells have been limited to activated lymphocytes. This study demonstrates, however, that cells of the macrophage lineage also are able to express the Ki-1 antigen. The Ki-1 antigen is absent from normal blood monocytes but expressed on up to 85% of macrophage-type cells developed during subsequent in vitro differentiation on Teflon membranes. Unlike other maturation-associated antigens, Ki-1 is found only at late stages of the macrophage primary cultures. Its expression can be enhanced by human interferon-gamma in a fashion similar to that of HLA-DR molecules. In addition, freshly explanted tumor cells from three patients with histopathologic and clinical features consistent with the diagnosis of true histiocytic lymphoma or malignant histiocytosis as well as the permanent cell line SU-DHL-1 could be demonstrated to express the Ki-1 antigen. The phenotype of histiocytic malignancy was further evaluated to be HLA-DR+MAX.26+CD25+-EMA+OKT9+Ki-1+. The results could indicate either that Hodgkin's lymphoma may arise not only from the lymphocyte but also from the macrophage lineage or may emphasize a macrophage involvement in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536522      PMCID: PMC1879544     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.

Authors:  G Delsol; T Al Saati; K C Gatter; J Gerdes; R Schwarting; P Caveriviere; F Rigal-Huguet; A Robert; H Stein; D Y Mason
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Immunoelectronmicroscopic investigation of Hodgkin's disease with monoclonal antibodies against histiocytes.

Authors:  M L Hansmann; H J Radzun; C Nebendahl; M R Parwaresch
Journal:  Eur J Haematol       Date:  1988-01       Impact factor: 2.997

3.  Microculture assay for human macrophage maturation in vitro. Cell-ELISA analysis of differentiation antigen expression.

Authors:  R Andreesen; A Mackensen; J Osterholz; W Brugger; G W Löhr
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

4.  Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.

Authors:  F Cabanillas; S Pathak; J Trujillo; G Grant; A Cork; F B Hagemeister; W S Velasquez; P McLaughlin; J Redman; R Katz
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

5.  Biochemical and structural properties of a Hodgkin's disease-related membrane protein.

Authors:  J F Nawrocki; E S Kirsten; R I Fisher
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

6.  Reed-Sternberg-cell/lymphocyte interaction.

Authors:  S V Payne; D B Jones; D H Wright
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

7.  Chromosome changes in Hodgkin's disease.

Authors:  G S Seif; A I Spriggs
Journal:  J Natl Cancer Inst       Date:  1967-09       Impact factor: 13.506

8.  A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene.

Authors:  P Fischer; E Nacheva; D Y Mason; P D Sherrington; C Hoyle; F G Hayhoe; A Karpas
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

9.  Cytotoxicity to tumour cells induced in human monocytes cultured in vitro in the presence of different sera.

Authors:  G Unsgaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1979-04

10.  Two neoplastic cell lines with unique features derived from Hodgkin's disease.

Authors:  M Schaadt; V Diehl; H Stein; C Fonatsch; H H Kirchner
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

View more
  15 in total

1.  Sialosylated Lewis chi expression in CD30-positive anaplastic large-cell lymphomas.

Authors:  K Kasai; Y Sato; S Kuwao; Y Kawakubo; H Inoue; T Kameya
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Anti-vimentin antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.

Authors:  A Carbone; A Gloghini; R Volpe; M Boiocchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.

Authors:  S M Hsu; Y S Ho; P L Hsu
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

4.  Sinus histiocytosis with massive lymphadenopathy: immunological, cytogenetic and molecular studies.

Authors:  S Sacchi; T Artusi; L Selleri; P Temperani; P Zucchini; A Vecchi; G Emilia; U Torelli
Journal:  Blut       Date:  1990-06

5.  Lymphoid hyperplasia with atypical dendritic/Langerhans cell proliferation mimicking Hodgkin lymphoma.

Authors:  Jayalakshmi P Balakrishna; Mark Raffeld; Elaine S Jaffe; Stefania Pittaluga
Journal:  Histopathology       Date:  2019-02-13       Impact factor: 5.087

6.  CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.

Authors:  U Latza; H D Foss; H Dürkop; F Eitelbach; K P Dieckmann; V Loy; M Unger; G Pizzolo; H Stein
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 7.  Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.

Authors:  Stephen L Rego; Rachel S Helms; Didier Dréau
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

8.  Interdigitating cell sarcoma (ICS). Evidence of interdigitating cell origin, immunocytochemical studies with monoclonal anti-ICS antibodies.

Authors:  S Nakamura; T Suchi; R Suzuki; N Takagi; K Kitoh; H Osada; R Ueda; T Takahashi; H Hiai; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Authors:  B Falini; L Flenghi; S Pileri; M Gambacorta; B Bigerna; H Durkop; F Eitelbach; J Thiele; R Pacini; A Cavaliere
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  CD30 expression by peripheral blood monocytes and hepatic macrophages in a child with miliary tuberculosis.

Authors:  M L Epstein; K P Windebank; A D Burt; L Thomas; A J Cant
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.